Selina Luger

Trials

Studies that name Selina Luger as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:36 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT00780052 · Infusional C-myb ASODN in Advanced Hematologic Malignancies

  Abramson Cancer Center at Penn Medicine · completed · Hematologic Malignancies · principal investigator
• Ph1/Ph2
  NCT00776373 · Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

  Abramson Cancer Center at Penn Medicine · terminated · ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia · principal investigator
• Ph3
  NCT00093470 · Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

  National Cancer Institute (NCI) · completed · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• EASTERN COOPERATIVE ONCOLOGY GROUP
  U10CA015488 · NCI · UNIVERSITY OF PENNSYLVANIA · fiscal years 2011 to 2013 · $333,233 awarded in 2013
  Same name and institution; not confirmed by an ID
• C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
  M01RR000040 · NCRR · UNIVERSITY OF PENNSYLVANIA · fiscal years 1996 to 2002 · $124,146 awarded in 2002
  Same name and institution; not confirmed by an ID
• PURGING OF LEUKEMIC BONE MARROW WITH ANTISENSE DNA
  F32CA009289 · NCI · UNIVERSITY OF PENNSYLVANIA · fiscal years 1992 to 1993 · $33,800 awarded in 1993
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• ECOG-ACRIN Network Group Operations Center
  U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026
  Named on NCT00093470
• Eastern Cooperative Oncology Group Operations Office
  U10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013
  Named on NCT00093470